Prof Shannon Weickert is the NSW Chair of Schizophrenia Research; a Professor at the School of Psychiatry, University of New South Wales and is a National Health and Medical Research Council (Australia) Principal Research Fellow. She leads a translational research program at Neuroscience Research Australia (NeuRA) that uses insights from the molecular and cellular neuropathology of schizophrenia to identify novel treatments for people with schizophrenia and contributes to the running of clinical trials.

Prof Shannon Weickert has published over 205 papers. Recently, Prof Shannon Weickert and her team have identified that there is neuroinflammation in the brains of people with schizophrenia suggesting anti-inflammatory agents may be of therapeutic benefit to those suffering with psychosis.

In 2015 Prof Shannon Weickert was awarded the competitive Nina Kondelos Prize by the Australian Neuroscience Society which is awarded to a female neuroscientist who is making outstanding contributions to basic or clinical research. In 2016 she was awarded the Biological Psychiatry Australia (BPA) Isaac Schweitzer Award. She was also honoured in 2016 by becoming a Fellow Member of the prestigious American College of Neuropsychopharmacology (ACNP).